胆碱能系统与结构性运用：毒扁豆碱在阿尔茨海默病中的进一步研究
Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease.
作者信息
Muramoto O, Sugishita M, Ando K
出版信息
J Neurol Neurosurg Psychiatry. 1984 May;47(5):485-91. doi: 10.1136/jnnp.47.5.485.
Abstract
Subcutaneous or intravenous administration of physostigmine improved the copying of geometric figures in three out of six patients with presumed Alzheimer's disease who showed a remarkable constructional disturbance. This improvement reached its maximum 30 to 60 minutes after the physostigmine administration. These results not only provide further evidence supporting the hypothesis that central cholinergic potentiation ameliorates some of the impairments of Alzheimer's disease, but implicate a possible important role of the cholinergic system in the integration of constructional praxis.
摘要
对六名疑似患有阿尔茨海默病且存在明显结构障碍的患者中的三名，皮下或静脉注射毒扁豆碱改善了其临摹几何图形的能力。这种改善在注射毒扁豆碱后30至60分钟达到最大程度。这些结果不仅为支持中枢胆碱能增强可改善阿尔茨海默病某些损伤这一假说提供了进一步证据，还表明胆碱能系统在结构实践整合中可能发挥重要作用。
相似文献
1
Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease.胆碱能系统与结构性运用：毒扁豆碱在阿尔茨海默病中的进一步研究
J Neurol Neurosurg Psychiatry. 1984 May;47(5):485-91. doi: 10.1136/jnnp.47.5.485.
2
Oral physostigmine treatment of patients with Alzheimer's disease.口服毒扁豆碱治疗阿尔茨海默病患者。
Am J Psychiatry. 1985 Jan;142(1):28-33. doi: 10.1176/ajp.142.1.28.
3
Effect of physostigmine on constructional and memory tasks in Alzheimer's disease.毒扁豆碱对阿尔茨海默病中结构性和记忆任务的影响。
Arch Neurol. 1979 Aug;36(8):501-3. doi: 10.1001/archneur.1979.00500440071014.
4
Cholinergic effects on constructional abilities and on mnemonic processes: a case report.胆碱能对建构能力和记忆过程的影响：一例报告
Psychol Med. 1987 May;17(2):329-33. doi: 10.1017/s0033291700024867.
5
Physostigmine ameliorates the delusions of Alzheimer's disease.
Biol Psychiatry. 1993 Apr 1;33(7):536-41. doi: 10.1016/0006-3223(93)90009-3.
6
Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies.阿尔茨海默病胆碱能缺陷的临床研究。II. 精神药理学研究。
J Am Geriatr Soc. 1985 Nov;33(11):749-57. doi: 10.1111/j.1532-5415.1985.tb04185.x.
7
Neuroendocrine responses to physostigmine in Alzheimer's disease.阿尔茨海默病中对毒扁豆碱的神经内分泌反应。
Arch Gen Psychiatry. 1989 Jun;46(6):535-40. doi: 10.1001/archpsyc.1989.01810060057009.
8
A pilot study of clonidine plus physostigmine in Alzheimer's disease.可乐定加毒扁豆碱治疗阿尔茨海默病的一项试点研究。
Dementia. 1994 Sep-Oct;5(5):243-6. doi: 10.1159/000106731.
9
Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.多剂量静脉注射毒扁豆碱增强阿尔茨海默病患者的记忆过程
Am J Psychiatry. 1982 Nov;139(11):1421-4. doi: 10.1176/ajp.139.11.1421.
10
Physostigmine-induced myoclonus in Alzheimer's disease.
Neurology. 1987 Feb;37(2):345-6. doi: 10.1212/wnl.37.2.345.
引用本文的文献
1
Physostigmine for Alzheimer's disease.用于治疗阿尔茨海默病的毒扁豆碱。
Cochrane Database Syst Rev. 2001;2001(2):CD001499. doi: 10.1002/14651858.CD001499.
2
Neuroimaging in Alzheimer's disease: relevance for treatment.阿尔茨海默病的神经影像学：对治疗的意义
Curr Psychiatry Rep. 2001 Feb;3(1):13-9. doi: 10.1007/s11920-001-0066-2.
3
The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.阿尔茨海默病的认知神经药理学：聚焦胆碱能系统。
Neurochem Res. 1998 May;23(5):787-94. doi: 10.1023/a:1022419712453.
4
Potential role of muscarinic agonists in Alzheimer's disease.毒蕈碱激动剂在阿尔茨海默病中的潜在作用。
Drugs Aging. 1997 Dec;11(6):450-9. doi: 10.2165/00002512-199711060-00004.
5
Effect of the putative cognitive enhancer, linopirdine (DuP 996), on quantal parameters of acetylcholine release at the frog neuromuscular junction.假定的认知增强剂来诺吡啶（DuP 996）对青蛙神经肌肉接头处乙酰胆碱释放的量子参数的影响。
Br J Pharmacol. 1994 Apr;111(4):1103-10. doi: 10.1111/j.1476-5381.1994.tb14858.x.
6
The metabolic brain pattern of young subjects given scopolamine.给予东莨菪碱的年轻受试者的大脑代谢模式。
Exp Brain Res. 1994;100(1):133-43. doi: 10.1007/BF00227285.
7
Beneficial effect of physostigmine on clinical amnesic behaviour and neuropsychological test results in a patient with a post-encephalitic amnesic syndrome.毒扁豆碱对一名脑炎后遗忘综合征患者临床遗忘行为和神经心理学测试结果的有益影响。
J Neurol Neurosurg Psychiatry. 1986 Sep;49(9):1088-90. doi: 10.1136/jnnp.49.9.1088.
8
Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG.通过心理测量测试、局部脑血流量（rCBF）测量和脑电图评估静脉注射毒扁豆碱治疗阿尔茨海默病的效果。
Psychopharmacology (Berl). 1987;93(1):31-5. doi: 10.1007/BF02439583.
9
Clinical trials in Alzheimer's disease. A report from the Medical Research Council Alzheimer's Disease Clinical Trials Committee.阿尔茨海默病的临床试验。医学研究理事会阿尔茨海默病临床试验委员会的报告。
J Neurol Neurosurg Psychiatry. 1991 Feb;54(2):178-81. doi: 10.1136/jnnp.54.2.178.
本文引用的文献
1
Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients.全髋关节置换术用于治疗阿尔茨海默病样痴呆：12例患者的初步研究
Biol Psychiatry. 1981 Feb;16(2):145-53.
2
Intrusions as a sign of Alzheimer dementia: chemical and pathological verification.
Ann Neurol. 1982 Feb;11(2):155-9. doi: 10.1002/ana.410110208.
3
Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia.毒扁豆碱和槟榔碱：静脉输注对早老性阿尔茨海默病痴呆的影响。
Br J Psychiatry. 1981 Jan;138:46-50. doi: 10.1192/bjp.138.1.46.
4
Memory enhancement with oral physostigmine in Alzheimer's disease.口服毒扁豆碱对阿尔茨海默病患者记忆功能的增强作用
N Engl J Med. 1983 Mar 24;308(12):720-1. doi: 10.1056/NEJM198303243081212.
5
Cerebral blood flow in dementia.痴呆症中的脑血流量
Arch Neurol. 1975 Sep;32(9):632-7. doi: 10.1001/archneur.1975.00490510088009.
6
Basal forebrain and hypothalamic connection to frontal and parietal cortex in the Rhesus monkey.
Science. 1975 Feb 21;187(4177):660-2. doi: 10.1126/science.1114317.
7
Physostigmine: effects on cognition and affect in normal subjects.毒扁豆碱：对正常受试者认知和情感的影响。
Psychopharmacology (Berl). 1976 Dec 21;51(1):23-7. doi: 10.1007/BF00426316.
8
Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex.恒河猴基底前脑向新皮层的富含乙酰胆碱酯酶的投射。
Brain Res. 1976 Jun 4;109(1):152-7. doi: 10.1016/0006-8993(76)90385-1.
9
Memory enhancement after physostigmine treatment in the amnesic syndrome.毒扁豆碱治疗遗忘综合征后的记忆增强。
Arch Neurol. 1977 Apr;34(4):215-9. doi: 10.1001/archneur.1977.00500160029004.
10
Effects of physostigmine and lecithin on memory in Alzheimer disease.
Ann Neurol. 1979 Sep;6(3):219-21. doi: 10.1002/ana.410060307.
Zotero 插件